CD44 expressed by myeloid cells promotes glioma invasion.
Saved in:
| Title: | CD44 expressed by myeloid cells promotes glioma invasion. |
|---|---|
| Authors: | Ivanova EL; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany., Costa B; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany., Eisemann T; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lohr S; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany., Boskovic P; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Eichwald V; Core Facility Small Animal Imaging Center, German Cancer Research Center (DKFZ), Heidelberg, Germany., Meckler J; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jugold M; Core Facility Small Animal Imaging Center, German Cancer Research Center (DKFZ), Heidelberg, Germany., Orian-Rousseau V; Karlsruhe Institute of Technology (KIT), Institute of Biological and Chemical Systems - Functional Molecular Systems (IBCS-FMS), Hermann-von-Helmholtz-Platz 1, Eggenstein-Leopoldshafen, Germany., Peterziel H; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Angel P; Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, German Cancer Research Center (DKFZ), Heidelberg, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Aug 04; Vol. 12, pp. 969787. Date of Electronic Publication: 2022 Aug 04 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
